THE MIDDLE EAST & AFRICA BIOCHIPS MARKET 2019-2027


MARKET OUTLOOK
According to Triton Market Research, the Middle East & Africa biochips market is anticipated to rise with a CAGR of 14.41% in estimated years 2019-2027.
The countries of Saudi Arabia, the UAE, Turkey, South Africa and rest of the Middle East and Africa together constitute the biochips market for the Middle East & African region.
There are notable investments in the biotechnology sector that aid the growth of biochips market. Private companies as well as various national governments are finding the benefits of biotechnology, and concerning this, all these organizations are highly involved in the investments in the biotechnology sector. Biochips play a vital role in molecular diagnostics, and their application in point-of-care diagnosis is expected to aid the development of personalized medicines. Focus towards personalized medicine-based analytics is enhancing growth of the biochips market. Personalized medicines have the highest safety margin and best response to ensure better patient care. 
Unclear regulatory guidelines for the use of biochips in disease diagnosis and drug development is creating a challenge for the global biochips market. The regulatory bodies of different countries have a different set of rules for medical devices, thus creating an ambiguous situation for the product manufacturers as due to lack of common standards a product certified in one country may not be fit for certification in another country. Unclear regulatory guidelines for the use of biochips is creating a challenge in the growth of global biochips market.
COMPETITIVE OUTLOOK
Some of the companies present in the biochips market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Gamida for Life Group, Cepheid, Inc., Biomerieux SA, Imgenex, Origene Technologies, Inc., Perkinelmer, Inc., Cybrdi, Inc., Agilent Technology, Inc., Biochain Institute, Inc., Fluidigm Corporation, Merck GMBH, Illumina, Inc. and Samsung Electronics, Inc.
TABLE OF CONTENT 
1. MIDDLE EAST & AFRICA BIOCHIPS MARKET - SUMMARY 
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.3. EVOLUTION & TRANSITION OF BIOCHIPS 
2.4. PORTER'S FIVE FORCE ANALYSIS
2.5. MARKET ATTRACTIVENESS MATRIX 
2.6. INDUSTRY COMPONENTS
2.7. REGULATORY FRAMEWORK
2.8. VENDOR SCORECARD
2.9. KEY IMPACT ANALYSIS 
2.10. MARKET OPPORTUNITY INSIGHTS
2.11. INDUSTRY PLAYER POSITIONING
2.12. KEY MARKET STRATEGIES 
2.13. MARKET DRIVERS
2.13.1. GROWTH IN PERSONALIZED MEDICINES
2.13.2. RISING INCIDENCES & TREATMENT OF CANCER 
2.13.3. CONSTANT RISE IN HEALTHCARE SPENDING WORLDWIDE
2.13.4. INCREASING NUMBER OF INVESTMENTS IN BIOTECHNOLOGY R&D
2.14. MARKET RESTRAINTS
2.14.1. INEQUALITIES IN HEALTHCARE ACCESS
2.14.2. INADEQUATE TECHNICAL AWARENESS RELATED TO BIOCHIPS
2.14.3. COMPLEXITY OF BIOLOGICAL SYSTEMS
2.15. MARKET OPPORTUNITIES
2.15.1. DEVELOPMENTS IN BIOCHIPS TECHNOLOGY
2.15.2. ASIA PACIFIC TO OFFER LUCRATIVE GROWTH OPPORTUNITIES
2.15.3. WIDENING APPLICATION AREAS OF BIOCHIPS 
2.16. MARKET CHALLENGES
2.16.1. AVAILABILITY OF SUBSTITUTE TECHNOLOGIES
2.16.2. UNCLEAR REGULATORY GUIDELINES
2.16.3. COST CONSTRAINTS
3. MIDDLE EAST & AFRICA BIOCHIPS MARKET OUTLOOK - BY TYPE
3.1. DNA CHIPS
3.1.1. AGRICULTURAL BIOTECHNOLOGY
3.1.2. CANCER DIAGNOSTICS & TREATMENT
3.1.3. DRUG DISCOVERY
3.1.4. GENE EXPRESSION
3.1.5. GENOMICS
3.1.6. SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
3.1.7. OTHER DNA CHIPS
3.2. LAB ON A CHIP
3.2.1. CLINICAL DIAGNOSTICS
3.2.2. DRUG DISCOVERY
3.2.3. GENOMICS
3.2.4. POINT OF CARE & IN VITRO DIAGNOSIS 
3.2.5. PROTEOMICS
3.2.6. OTHER LAB ON A CHIP
3.3. PROTEIN CHIPS
3.3.1. DIAGNOSTICS
3.3.2. DRUG DISCOVERY
3.3.3. EXPRESSION PROFILING
3.3.4. HIGH THROUGHPUT SCREENING
3.3.5. PROTEOMICS
3.3.6. OTHER PROTEIN CHIPS
3.4. OTHER CHIPS
3.4.1. CELL ARRAYS
3.4.2. TISSUE ARRAYS
4. MIDDLE EAST & AFRICA BIOCHIPS MARKET OUTLOOK - BY SUBSTRATE MATERIAL
4.1. GLASS
4.2. POLYMERS
4.3. SILICON
4.4. OTHER SUBSTRATE MATERIALS
5. MIDDLE EAST & AFRICA BIOCHIPS MARKET OUTLOOK - BY END USER
5.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
5.2. HOSPITALS AND DIAGNOSTICS CENTERS
5.3. ACADEMIC AND RESEARCH INSTITUTE
6. MIDDLE EAST & AFRICA BIOCHIPS MARKET - REGIONAL OUTLOOK 
6.1. UNITED ARAB EMIRATES 
6.2. TURKEY 
6.3. SAUDI ARABIA 
6.4. SOUTH AFRICA
6.5. REST OF MIDDLE EAST & AFRICA 
7. COMPETITIVE LANDSCAPE
7.1. AGILENT TECHNOLOGY INC.
7.2. BIOCHAIN INSTITUTE INC.
7.3. BIOMERIEUX SA
7.4. BIO-RAD LABORATORIES INC.
7.5. CEPHEID INC.
7.6. CYBRDI INC.
7.7. FLUIDIGM CORPORATION
7.8. GAMIDA FOR LIFE GROUP
7.9. ILLUMINA INC.
7.10. IMGENEX
7.11. MERCK GMBH
7.12. ORIGENE TECHNOLOGIES INC.
7.13. PERKINELMER INC.
7.14. SAMSUNG ELECTRONICS INC.
7.15. THERMO FISHER SCIENTIFIC INC.
8. METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE 
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY


 
TABLE LIST
TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET 
TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET 
TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET
TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET
TABLE 5. NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017 
TABLE 6. MIDDLE EAST & AFRICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 7. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION) 
TABLE 8. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION) 
TABLE 9. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)
TABLE 10. MIDDLE EAST & AFRICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)




FIGURE LIST
FIGURE 1. MIDDLE EAST & AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET
FIGURE 3. KEY IMPACT ANALYSIS
FIGURE 4. TIMELINE OF BIOCHIPS
FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018
FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018 
FIGURE 7. INDUSTRY COMPONENTS OF BIOCHIPS MARKET 
FIGURE 8. KEY PLAYERS POSITIONING IN 2018 (%)
FIGURE 9. WORLDWIDE HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP) 
FIGURE 10. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE 
FIGURE 11. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION) 
FIGURE 12. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)
FIGURE 13. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)
FIGURE 14. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) 
FIGURE 15. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION) 
FIGURE 16. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 17. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION) 
FIGURE 18. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 19. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 20. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 21. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 22. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 23. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $ MILLION) 
FIGURE 24. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION) 
FIGURE 25. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 26. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 27. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 28. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 29. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)
FIGURE 30. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)
FIGURE 31. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 32. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 33. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 34. MIDDLE EAST & AFRICA OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 35. MIDDLE EAST & AFRICA OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 36. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS) 
FIGURE 37. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)
FIGURE 38. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)
FIGURE 39. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
FIGURE 40. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)
FIGURE 41. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS)
FIGURE 42. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)
FIGURE 43. MIDDLE EAST & AFRICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %) 
FIGURE 44. UNITED ARAB EMIRATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 45. SAUDI ARABIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 46. TURKEY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 47. SOUTH AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 
FIGURE 48. REST OF MIDDLE EAST & AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)

TABLE LIST TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET TABLE 5. NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017 TABLE 6. MIDDLE EAST & AFRICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION) TABLE 7. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION) TABLE 8. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION) TABLE 9. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION) TABLE 10. MIDDLE EAST & AFRICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION) FIGURE LIST FIGURE 1. MIDDLE EAST & AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET FIGURE 3. KEY IMPACT ANALYSIS FIGURE 4. TIMELINE OF BIOCHIPS FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018 FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018 FIGURE 7. INDUSTRY COMPONENTS OF BIOCHIPS MARKET FIGURE 8. KEY PLAYERS POSITIONING IN 2018 (%) FIGURE 9. WORLDWIDE HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP) FIGURE 10. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE FIGURE 11. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION) FIGURE 12. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION) FIGURE 13. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION) FIGURE 14. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) FIGURE 15. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION) FIGURE 16. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION) FIGURE 17. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION) FIGURE 18. MIDDLE EAST & AFRICA DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION) FIGURE 19. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION) FIGURE 20. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION) FIGURE 21. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) FIGURE 22. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION) FIGURE 23. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $ MILLION) FIGURE 24. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION) FIGURE 25. MIDDLE EAST & AFRICA LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION) FIGURE 26. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION) FIGURE 27. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION) FIGURE 28. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION) FIGURE 29. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION) FIGURE 30. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION) FIGURE 31. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION) FIGURE 32. MIDDLE EAST & AFRICA PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION) FIGURE 33. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION) FIGURE 34. MIDDLE EAST & AFRICA OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION) FIGURE 35. MIDDLE EAST & AFRICA OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION) FIGURE 36. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS) FIGURE 37. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS) FIGURE 38. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS) FIGURE 39. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS) FIGURE 40. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS) FIGURE 41. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS) FIGURE 42. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS) FIGURE 43. MIDDLE EAST & AFRICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %) FIGURE 44. UNITED ARAB EMIRATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 45. SAUDI ARABIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 46. TURKEY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 47. SOUTH AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) FIGURE 48. REST OF MIDDLE EAST & AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Biotechnology Reports

North America Creatinine Measurement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Kits, Reagents); Type (Enzymatic Method, Jaffe's Kinetic Method); Sample Type (Blood or Serum, Urine); End-User (Hospitals, Diagnostic Laboratories, Others), and Country

The North American Creatinine Measurement Market is expected to reach US$ 269.75 million in 2027 from US$ 148.79 million in 2019. The market is estimated to grow with a CAGR of 7.8% from 2020-2027. The growth of the creatinine measurement market is a...

Europe Biodefense Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography

Europe, the Biodefense Market, is anticipated to reach US$ 2,516.91 Mn in 2027 from US$ 1,286.58 Mn in 2019. The market is projected to grow with a CAGR of 8.8% from 2020-2027. The Biodefense Market is growing primarily due to the presence of favorab...

Asia Pacific Biodefense Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography

Asia Pacific, the Biodefense Market, is anticipated to reach US$ 1,520.67 Mn in 2027 from US$ 723.70 Mn in 2019. The market is projected to grow with a CAGR of 9.8% from 2020-2027. The Biodefense Market is growing primarily due to the presence of fav...

North America Biodefense Market to 2027 - Regional Analysis and Forecasts by North America Biodefense Market to 2027 - Regional Analysis and Forecasts by Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others); and Country

The North American biodefense market is estimated to reach US$ 3,357.83 Mn by 2027 from US$ 1,569.29 Mn in 2019; it is projected to grow at a CAGR of 10.1% from 2019 to 2027. The growth of the biodefense market is primarily ascribed to the presence o...

Other Reports by Triton Market Research

GLOBAL RECYCLED GLASS MARKET 2020-2028

MARKET OUTLOOK According to Triton, the global recycled glass market is expected to display a positive market trend over the forecast years 2020-2028, exhibiting a CAGR of 6.02% (by revenue) and 6.25% (by volume). Glass has several advantageous prope...

GLOBAL PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per an analysis by the Triton Market Research on the global PP nonwoven market, it is estimated that the industry would show growth at a CAGR of 7.05% in the period 2020-2028. PP nonwoven material is used in the production of diaper...

NORTH AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report on the North American PP nonwoven market depicts that the market is likely to show growth at a CAGR of 6.87% in the forecast period between 2020 and 2028. The United States and Canada comprises the North...

MIDDLE EAST AND AFRICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK As per a Triton Market Research report, the PP nonwoven market in the Middle East and Africa is set to accelerate at a CAGR of 8.51% during the forecast period 2020-2028. Saudi Arabia, Turkey, the United Arab Emirates and the Rest of t...

LATIN AMERICA PP NONWOVEN MARKET 2020-2028

MARKET OUTLOOK A Triton Market Research report illustrates that the Latin American PP nonwoven market would exhibit a CAGR of 7.28% during the estimated period 2020-2028. Brazil, Mexico and the Rest of Latin America together form the PP nonwoven mark...

Publisher: Triton Market Research